RocRock Biotechnology
PrivateLast Round
Series A
Nov 20, 2025
Total Funding Raised
$6.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RocRock Biotechnology is a biotechnology company that develops engineered macrophage technology and macrophage-based drug therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RocRock Biotechnology Comparables
Compare RocRock Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellOrigin Biotech | 88% | |
| Carisma Therapeutics | 81% | |
| Thunder Biotech | 81% | |
RocRock Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 20, 2025 | ||||
| Angel | Oct 1, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
$7M round completed.
- Oct 1, 2022
Completed an angel funding round.
RocRock Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RocRock Biotechnology's valuation, stock price, and market status.